SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-005855
Filing Date
2021-05-05
Accepted
2021-05-05 12:46:36
Documents
78
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q clvs-20210331x10q.htm   iXBRL 10-Q 1845088
2 EX-10.41 clvs-20210331xex10d41.htm EX-10.41 189576
3 EX-10.42 clvs-20210331xex10d42.htm EX-10.42 106334
4 EX-31.1 clvs-20210331xex31d1.htm EX-31.1 15845
5 EX-31.2 clvs-20210331xex31d2.htm EX-31.2 16038
6 EX-32.1 clvs-20210331xex32d1.htm EX-32.1 6459
7 EX-32.2 clvs-20210331xex32d2.htm EX-32.2 6539
  Complete submission text file 0001558370-21-005855.txt   8258952

Data Files

Seq Description Document Type Size
8 EX-101.SCH clvs-20210331.xsd EX-101.SCH 51041
9 EX-101.CAL clvs-20210331_cal.xml EX-101.CAL 74812
10 EX-101.DEF clvs-20210331_def.xml EX-101.DEF 140583
11 EX-101.LAB clvs-20210331_lab.xml EX-101.LAB 508009
12 EX-101.PRE clvs-20210331_pre.xml EX-101.PRE 345292
13 EXTRACTED XBRL INSTANCE DOCUMENT clvs-20210331x10q_htm.xml XML 1560333
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 21892179
SIC: 2834 Pharmaceutical Preparations